Media Summary: "Synthetic biology and next-generation diagnostics" "New chemical engineering approaches to convergence" Robert S. Langer, Koch Institute, MIT Session III: Nanomedicine, ... Introductory Remarks Tyler Jacks, Koch Institute, MIT

2017 Summer Symposium James Collins - Detailed Analysis & Overview

"Synthetic biology and next-generation diagnostics" "New chemical engineering approaches to convergence" Robert S. Langer, Koch Institute, MIT Session III: Nanomedicine, ... Introductory Remarks Tyler Jacks, Koch Institute, MIT "Understanding transcription and splicing heterogeneity in cancer progression" Daniel Larson, Center for Cancer Research, ... "Targeting Aggressive Cancers Nanolayers at a Time: A Platform Approach to Engineered Nanomedicine" Paula T. Hammond, ... "Computational Models of Cancer" Franziska Michor, Dana-Farber Cancer Institute Session II: Complex Molecular Networks, ...

"Spherical Nucleic Acids as a Powerful New Platform for Cancer Therapy" Chad A. Mirkin, Northwestern University Session III: ... "Convergence in Health" Panelists: Marc N. Casper, President and CEO, Thermo Fisher Scientific Nancy Simonian, CEO, Syros ... Introductory Remarks Phillip A. Sharp, Koch Institute, MIT Altering Nature by Gene Editing: We Can, but Should We? –

Photo Gallery

2017 Summer Symposium: James Collins
2017 Summer Symposium: Robert S. Langer
2017 Summer Symposium: Tyler Jacks
2017 Summer Symposium: Daniel Larson
2017 Summer Symposium: Paula T. Hammond
2017 Summer Symposium: Franziska Michor
2017 Summer Symposium: Chad A. Mirkin
2010 KI Symposium: James Collins (Part 2 of 3)
2017 Summer Symposium: Panel - "Convergence in Health"
2017 Summer Symposium: Phillip A. Sharp
2010 KI Symposium: James Collins (Part 1 of 3)
2010 KI Symposium: James Collins (Part 3 of 3)
View Detailed Profile
2017 Summer Symposium: James Collins

2017 Summer Symposium: James Collins

"Synthetic biology and next-generation diagnostics"

2017 Summer Symposium: Robert S. Langer

2017 Summer Symposium: Robert S. Langer

"New chemical engineering approaches to convergence" Robert S. Langer, Koch Institute, MIT Session III: Nanomedicine, ...

2017 Summer Symposium: Tyler Jacks

2017 Summer Symposium: Tyler Jacks

Introductory Remarks Tyler Jacks, Koch Institute, MIT http://ki.mit.edu/news/

2017 Summer Symposium: Daniel Larson

2017 Summer Symposium: Daniel Larson

"Understanding transcription and splicing heterogeneity in cancer progression" Daniel Larson, Center for Cancer Research, ...

2017 Summer Symposium: Paula T. Hammond

2017 Summer Symposium: Paula T. Hammond

"Targeting Aggressive Cancers Nanolayers at a Time: A Platform Approach to Engineered Nanomedicine" Paula T. Hammond, ...

2017 Summer Symposium: Franziska Michor

2017 Summer Symposium: Franziska Michor

"Computational Models of Cancer" Franziska Michor, Dana-Farber Cancer Institute Session II: Complex Molecular Networks, ...

2017 Summer Symposium: Chad A. Mirkin

2017 Summer Symposium: Chad A. Mirkin

"Spherical Nucleic Acids as a Powerful New Platform for Cancer Therapy" Chad A. Mirkin, Northwestern University Session III: ...

2010 KI Symposium: James Collins (Part 2 of 3)

2010 KI Symposium: James Collins (Part 2 of 3)

Part 2 of

2017 Summer Symposium: Panel - "Convergence in Health"

2017 Summer Symposium: Panel - "Convergence in Health"

"Convergence in Health" Panelists: Marc N. Casper, President and CEO, Thermo Fisher Scientific Nancy Simonian, CEO, Syros ...

2017 Summer Symposium: Phillip A. Sharp

2017 Summer Symposium: Phillip A. Sharp

Introductory Remarks Phillip A. Sharp, Koch Institute, MIT http://ki.mit.edu/news/

2010 KI Symposium: James Collins (Part 1 of 3)

2010 KI Symposium: James Collins (Part 1 of 3)

Part 1 of

2010 KI Symposium: James Collins (Part 3 of 3)

2010 KI Symposium: James Collins (Part 3 of 3)

Part 3 of

James Collins - Altering Nature by Gene Editing: We Can, but Should We?

James Collins - Altering Nature by Gene Editing: We Can, but Should We?

Altering Nature by Gene Editing: We Can, but Should We? –